Merck loses bid to revive $200 million Gilead verdict at U.S. high court Reuters
The U.S. Supreme Court on Monday handed a defeat to Merck & Co by refusing to hear its appeal of a ruling that it had dishonestly obtained patent rights and ...
View full coverage on Google News (CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment